|
|
||||||||
VASCULAR BIOLOGY
Department of Epidemiology, Research Institute, National Cardiovascular Center, Suita, Osaka, Japan
Submitted 27 September 2005 ; accepted in final form 4 January 2006
Nanoscale materials are presently under development for diagnostic (nanomedicine) and electronic purposes. In contrast to the potential benefits of nanotechnology, the effects of nanomaterials on human health are poorly understood. Nanomaterials are known to translocate into the circulation and could thus directly affect vascular endothelial cells (ECs), causing vascular injury that might be responsible for the development of atherosclerosis. To explore the direct effects of nanomaterials on endothelial toxicity, human umbilical vein ECs were treated with 1100 µg/ml hydroxyl fullerene [C60(OH)24; mean diameter, 7.1 ± 2.4 nm] for 24 h. C60(OH)24 induced cytotoxic morphological changes such as cytosolic vacuole formation and decreased cell density in a dose-dependent manner. Lactate dehydrogenase assay revealed that a maximal dose of C60(OH)24 (100 µg/ml) induced cytotoxic injury. Proliferation assay also showed that a maximal dose of C60(OH)24 inhibited EC growth. C60(OH)24 did not seem to induce apoptosis but caused the accumulation of polyubiquitinated proteins and facilitated autophagic cell death. Formation of autophagosomes was confirmed on the basis of Western blot analysis using a specific marker, light chain 3 antibody, and electron microscopy. Chronic treatment with low-dose C60(OH)24 (10 µg/ml for 8 days) inhibited cell attachment and delayed EC growth. In the present study, we have examined, for the first time, the toxicity of water-soluble fullerenes to ECs. Although fullerenes changed morphology in a dose-dependent manner, only maximal doses of fullerenes caused cytotoxic injury and/or death and inhibited cell growth. EC death seemed to be caused by activation of ubiquitin-autophagy cell death pathways. Although exposure to nanomaterials appears to represent a risk for cardiovascular disorders, further in vivo validations are necessary.
nanomaterials; ubiquitin proteasome; autophagy; atherosclerosis
This article has been cited by other articles:
![]() |
W. Martinet and G. R.Y. De Meyer Autophagy in Atherosclerosis: A Cell Survival and Death Phenomenon With Therapeutic Potential Circ. Res., February 13, 2009; 104(3): 304 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamawaki, K. Saito, M. Okada, and Y. Hara Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells Am J Physiol Cell Physiol, December 1, 2008; 295(6): C1510 - C1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Stern, B. S. Zolnik, C. B. McLeland, J. Clogston, J. Zheng, and S. E. McNeil Induction of Autophagy in Porcine Kidney Cells by Quantum Dots: A Common Cellular Response to Nanomaterials? Toxicol. Sci., November 1, 2008; 106(1): 140 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Stern and S. E. McNeil Nanotechnology Safety Concerns Revisited Toxicol. Sci., January 1, 2008; 101(1): 4 - 21. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |